Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Albert Patterson currently holds 48,690 shares of Sagent Pharmaceuticals, Inc. (SGNT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Albert Patterson has been a net neutral trader of SGNT stock. They have purchased $0 and sold $0 worth of shares.
Albert Patterson's most recent insider trade was on Mar 19, 2016, when they sold 66 shares at $12.39 per share.
Albert Patterson serves as Executive at Sagent Pharmaceuticals, Inc. (SGNT). They have executed 21 insider transactions totaling $0 over their tenure at the company.
Albert Patterson holds the position of Executive at Sagent Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 14 years and currently hold a stake valued at $0.
Albert Patterson has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Albert Patterson was on Aug 16, 2012, when they sold $55.0K worth of SGNT shares. This transaction involved 12,759 shares at $4.31 per share.
Albert Patterson currently owns 48,690 shares of Sagent Pharmaceuticals, Inc. (SGNT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Albert Patterson's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Albert Patterson has 21 Form 4 filings on record as an insider at Sagent Pharmaceuticals, Inc..
Set alerts for Albert Patterson and 40,000+ other insiders.